RenovoRx (RNXT) CFO granted 80,000-share RSU-based stock award

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

VOLL MARK reported acquisition or exercise transactions in this Form 4 filing.

RenovoRx, Inc. reported that Chief Financial Officer Mark Voll received an award of 80,000 shares of Common Stock on April 3, 2026, reflecting stock-based compensation rather than an open-market purchase. The award stems from grants of restricted stock units for his service as CFO.

The footnote explains this consists of 8,777 RSUs for February 2026, 12,270 RSUs for March 2026, and 58,953 RSUs for future service, with the February and March RSUs fully vested upon grant and the remainder vesting monthly. After the transaction, he holds 117,380 shares directly and 97,200 shares indirectly through the Voll Family Trust.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider VOLL MARK

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	80,000	$0.00	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 117,380 shares (Direct); Common Stock — 97,200 shares (Indirect, Voll Family Trust DTD 6/23/2010 Mark Voll TTEE)

Footnotes (1)

[object Object]

Key Figures

Stock grant: 80,000 shares February 2026 RSUs: 8,777 units March 2026 RSUs: 12,270 units +4 more

7 metrics

Stock grant 80,000 shares Common Stock awarded to CFO on April 3, 2026

February 2026 RSUs 8,777 units RSUs for CFO service in February 2026, fully vested

March 2026 RSUs 12,270 units RSUs for CFO service in March 2026, fully vested

Future service RSUs 58,953 units RSUs for future CFO service, subject to monthly vesting

Direct holdings after grant 117,380 shares RenovoRx Common Stock held directly by CFO after transaction

Indirect trust holdings 97,200 shares Common Stock held via Voll Family Trust DTD 6/23/2010

Grant price per share $0.0000 Indicates no cash paid by CFO for granted shares

Key Terms

restricted stock units ("RSUs"), fully vested upon grant, monthly vesting, closing price on the last trading day of the month, +1 more

5 terms

restricted stock units ("RSUs") financial

"The reported transaction involved the Reporting Person's receipts of (i) a grant of 8,777 restricted stock units ("RSUs") for his service..."

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

fully vested upon grant financial

"RSUs for his service as the Chief Financial Officer of the Issuer for February 2026, which are fully vested upon grant..."

monthly vesting financial

"a grant of 58,953 RSUs for his future service as the Chief Financial Officer of the Issuer, subject to monthly vesting..."

closing price on the last trading day of the month financial

"with the RSUs valued based on the closing price on the last trading day of the month in which the services were performed."

Voll Family Trust DTD 6/23/2010 Mark Voll TTEE financial

"nature_of_ownership: "Voll Family Trust DTD 6/23/2010 Mark Voll TTEE""

Form 4 Insider Transactions: What Each Field Means →

04/07/2026 - 08:00 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

VOLL MARK

(Last)

(First)

(Middle)

C/O RENOVORX, INC.

2570 W EL CAMINO REAL, SUITE 320

(Street)

MOUNTAIN VIEW

CALIFORNIA

94040

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
RenovoRx, Inc. [ RNXT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	04/03/2026	⁽¹⁾	A		80,000⁽¹⁾	A	$0⁽¹⁾	117,380	D
Common Stock								97,200	I	Voll Family Trust DTD 6/23/2010 Mark Voll TTEE

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The reported transaction involved the Reporting Person's receipts of (i) a grant of 8,777 restricted stock units ("RSUs") for his service as the Chief Financial Officer of the Issuer for February 2026, which are fully vested upon grant, and (ii) a grant of 12,270 RSUs for his service as the Chief Financial Officer for March 2026, which are fully vested upon grant and (iii) a grant of 58,953 RSUs for his future service as the Chief Financial Officer of the Issuer, subject to monthly vesting with the RSUs valued based on the closing price on the last trading day of the month in which the services were performed.

	/s/ Mark Voll	04/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did RenovoRx (RNXT) CFO Mark Voll report in this Form 4?

RenovoRx CFO Mark Voll reported receiving 80,000 shares of Common Stock as stock-based compensation. These shares arise from restricted stock unit grants tied to his service as Chief Financial Officer in early 2026 and for future service with specified vesting terms.

How many RenovoRx (RNXT) shares were granted to the CFO in this filing?

The Form 4 shows a grant of 80,000 shares of RenovoRx Common Stock to CFO Mark Voll. This amount reflects the share output of several restricted stock unit awards for February 2026, March 2026, and future service as detailed in the accompanying footnote.

Are the RenovoRx (RNXT) CFO’s new shares from an open-market purchase?

No, the new shares are not from an open-market purchase. The filing classifies the 80,000-share increase as a grant or award acquisition, meaning the shares come from compensation-related restricted stock unit grants rather than buying shares on the market.

What vesting terms apply to the RenovoRx (RNXT) CFO’s RSU awards?

The footnote states 8,777 RSUs for February 2026 and 12,270 RSUs for March 2026 are fully vested upon grant. An additional 58,953 RSUs for future service vest monthly, based on the closing price on the last trading day of each relevant month.

How many RenovoRx (RNXT) shares does the CFO hold after this transaction?

After the reported grant, CFO Mark Voll holds 117,380 RenovoRx Common Stock shares directly. He also has 97,200 shares held indirectly through the Voll Family Trust DTD 6/23/2010, where he is identified as trustee in the nature-of-ownership disclosure.

What indirect ownership does the RenovoRx (RNXT) CFO disclose in this Form 4?

The Form 4 lists an indirect holding of 97,200 RenovoRx Common Stock shares. These are owned through the “Voll Family Trust DTD 6/23/2010 Mark Voll TTEE,” indicating the shares are held in a family trust with Mark Voll as trustee.